MicroAlgo Inc. (the 'Company' or 'MicroAlgo') (NASDAQ: MLGO), today announced the proposal of a powerful solution-a multi-objective evolutionary search strategy, which is an innovative automated tool ...

A new advanced artificial intelligence (AI) algorithm more accurately model how genes associated with specific autoimmune diseases are expressed and regulated and to identify additional genes of risk.